Advancements in hit identification for membrane protein drug discovery
Drug Target Review
APRIL 7, 2025
This stability enables the application of hit identification approaches such as fragment-based screening (FBS). The development of PoLiPa technology marks a new era in membrane protein drug discovery, rendering otherwise difficult targets accessible to structural biology, biophysical assays and other screening technologies.
52 
Let's personalize your content